Depression Clinical Trial
Official title:
Telepsychology-Service Delivery for Depressed Elderly Veterans
The purpose of this study is to see whether therapy for elderly adults with major depression can be delivered effectively using videoconferencing technology ("telepsychology"), which allows a therapist and patient who are not in the same room as one another to communicate. We are interested in learning if this form of mental health service delivery is an acceptable alternative to traditional face-to-face therapy delivered with the therapist in the same room as the patient.
ABSTRACT
Telepsychology: Service Delivery for Depressed Elderly Veterans
1. Objective: The immediate objective is to test the hypothesis that a novel mode of
geriatric mental health service delivery, using in-home videoconferencing technology
("Telepsychology"), will be as effective as the traditional mode of service delivery
("Same-Room") for treating older adult veterans suffering from major depressive
disorder (MDD). The ultimate objective is to help the VA develop and evaluate
strategies for providing mental health care to elderly veterans who live in rural
areas, many of whom are minorities.
2. Research Design: This project is a 4-year prospective, randomized between-groups study
comparing the efficacy of an intervention for geriatric depression delivered via two
different modes (Telepsychology, Same-Room). Participants in the Telepsychology
condition will receive care in their own home via videophone contact with a therapist
at the Charleston VA Medical Center; participants in the Same-room condition will
receive their care via traditional face-to-face therapy sessions held at the Charleston
VA Medical Center. Two-hundred twenty-four (224) participants will be recruited from
primary care and mental health clinics within the Charleston VA Medical Center
catchment area. Treatment will be administered over an 8-week period (active treatment
phase); and participants will be followed for an additional 12-months (follow-up phase)
to ascertain longer-term effects of treatment on three outcome domains: (1) clinical
outcomes: symptom severity and social functioning; (2) process outcomes: patient
satisfaction and acceptance, treatment credibility, session attendance, treatment
adherence, and treatment dropout; and (3) cost-effectiveness.
3. Methodology: Population and Sample: Participants will be elderly veterans (N = 224),
age 60 and above, with diagnoses of major depressive disorder (MDD). Based on our
previous research and local demographics, we expect approximately 40% of our sample
will be African-American. Types of Data: To assess outcome, we will use measures that
have been widely validated in the clinical evaluation of older adults with MDD.
Measures will be collected at pre-treatment, post-treatment, 3-, and 12-month
follow-up. Data Analyses Plan: The primary clinical response variable is proportion (%)
of patients who respond to treatment, where treatment response is defined as at least a
50% improvement from baseline to post-treatment level on the GDS (percent change from
baseline:[baseline-post]/baseline >= 50%). Two approaches to estimation of the primary
response variable will be taken. The first approach will estimate proportion of
responders (% responders) at the end of the 8-week active treatment course based on the
total number randomized to each treatment. This is equivalent to a "worst case"
analysis in which all premature exits (for whom response status is missing) will be
treated as non-responders. We will also estimate proportion of responders for each
treatment based on only those who complete the 8-week treatment course (completer
analysis). The second approach will use multivariable logistic regression to estimate
adjusted % responders. Finally, we will conduct a range of analyses between
African-American and Caucasian subjects to look at differential efficacy, patient
preferences and satisfaction, and adherence across racial groups.
4. Findings: Analysis of data is currently in process.
5. Clinical Relationship: Findings will allow for improved service delivery and access to
elderly depressed veterans.
6. Impact/Significance: The telepsychology literature is undeveloped. The VA has made
telehealth a priority strategy for bringing quality services to veterans in rural
areas. Therefore, research that addresses the efficacy of this mode of service delivery
is acutely needed. If Telepsychology efficacy and cost-effectiveness is demonstrated,
then future research and program development will bring specialized mental health
services to the homes of minority veterans or VA community based outpatient clinics.
Further, if Telepsychology effectiveness can be empirically established, then we can
proceed with research that examines a range of important system issues. Thus, this
project represents a step in a major programmatic line of research in mental health
service delivery to rural and underserved populations.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |